Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FR03X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,252
Award facts
- Contract value 100% obligated
- $31,251.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $31,251.52 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen 2ml injections on December 16, 2025, with an ultimate completion date of December 17, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Cosentyx is a biologic medication used to treat various inflammatory and autoimmune conditions, representing part of AmerisourceBergen's critical role as a major pharmaceutical distributor supplying the federal government's medical needs.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a long-standing federal vendor, AmerisourceBergen has demonstrated capability to fulfill competitive federal procurement requirements across multiple therapeutic domains through firm fixed-price delivery orders of varying values.
Quick answers
Who was awarded contract SPE2DR26FR03X?
SPE2DR26FR03X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 16, 2025.
How much is contract SPE2DR26FR03X worth?
The government has obligated $31,252 on SPE2DR26FR03X.
Is contract SPE2DR26FR03X an order under another contract?
Yes. SPE2DR26FR03X is a delivery order under SPE2DR25D2003, an indefinite delivery contract.
Was contract SPE2DR26FR03X competed?
The extent of competition for SPE2DR26FR03X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award